Proteomics International Laboratories Limited
ASX:PIQ.AX
0.7 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.892 | 0.73 | 1.489 | 1.311 | 1.423 | 1.468 | 1.176 | 0.925 | 0.817 | 0.608 | 1.128 | 1.321 |
| Cost of Revenue
| 8.294 | 2.345 | 2.058 | 0.814 | 0.838 | 0.088 | 2.507 | 2.28 | 1.897 | 0.326 | 0.395 | 0.066 |
| Gross Profit
| -7.402 | -1.615 | -0.569 | 0.497 | 0.585 | 1.38 | -1.33 | -1.355 | -1.08 | 0.282 | 0.733 | 1.256 |
| Gross Profit Ratio
| -8.297 | -2.211 | -0.382 | 0.379 | 0.411 | 0.94 | -1.131 | -1.464 | -1.322 | 0.464 | 0.65 | 0.95 |
| Reseach & Development Expenses
| 1.83 | 2.077 | 1.906 | 0.701 | 0.782 | 0.722 | 0 | 0 | 0 | 0 | 0 | 0.157 |
| General & Administrative Expenses
| 5.551 | 5.109 | 4.359 | 2.874 | 2.24 | 2.156 | 1.669 | 1.385 | 1.708 | 0.926 | 0.133 | 0.22 |
| Selling & Marketing Expenses
| -3.828 | 0 | 0.12 | 0.057 | 0.081 | 0.227 | 0.104 | 0.137 | 0.138 | 0.06 | 0.802 | 0.045 |
| SG&A
| 1.723 | 5.109 | 4.479 | 2.931 | 2.32 | 2.383 | 1.773 | 1.522 | 1.846 | 0.986 | 0.936 | 1.232 |
| Other Expenses
| 0.22 | 2.434 | 1.942 | 1.64 | 1.568 | 0.969 | 0.943 | -8.256 | 0.578 | -0.207 | 0 | 0 |
| Operating Expenses
| 1.503 | 9.547 | 8.407 | 5.818 | 4.737 | 4.538 | 3.524 | -6.464 | 2.725 | 1.484 | 0.949 | 1.468 |
| Operating Income
| -8.905 | -6.366 | -4.977 | -3.083 | -1.998 | -1.85 | -2.348 | 7.389 | -1.908 | -0.876 | -0.215 | -0.213 |
| Operating Income Ratio
| -9.981 | -8.716 | -3.342 | -2.352 | -1.404 | -1.26 | -1.996 | 7.985 | -2.336 | -1.44 | -0.191 | -0.161 |
| Total Other Income Expenses Net
| 0.267 | 2.445 | 1.942 | 1.64 | 1.568 | 0.969 | 0.943 | -8.256 | 0.578 | -0.207 | -0.034 | -0.029 |
| Income Before Tax
| -8.638 | -6.234 | -4.973 | -2.86 | -1.744 | -2.08 | -1.44 | -0.916 | -1.328 | -1.131 | -0.249 | -0.242 |
| Income Before Tax Ratio
| -9.683 | -8.536 | -3.339 | -2.182 | -1.225 | -1.417 | -1.224 | -0.99 | -1.626 | -1.859 | -0.221 | -0.183 |
| Income Tax Expense
| -2.156 | -0.148 | 1.943 | 1.64 | 1.577 | 0.996 | 0.969 | -8.191 | 0.611 | 0.018 | 0.003 | 0.009 |
| Net Income
| -6.376 | -6.234 | -4.973 | -2.86 | -1.744 | -2.08 | -1.44 | -0.916 | -1.328 | -1.149 | -0.247 | -0.251 |
| Net Income Ratio
| -7.147 | -8.536 | -3.339 | -2.182 | -1.225 | -1.417 | -1.224 | -0.99 | -1.626 | -1.889 | -0.219 | -0.19 |
| EPS
| -0.051 | -0.054 | -0.047 | -0.028 | -0.02 | -0.026 | -0.024 | -0.017 | -0.026 | -0.044 | -0.014 | 0 |
| EPS Diluted
| -0.051 | -0.054 | -0.047 | -0.028 | -0.02 | -0.026 | -0.024 | -0.017 | -0.026 | -0.044 | -0.014 | 0 |
| EBITDA
| -8.177 | -8.299 | -4.556 | -2.487 | -1.371 | -1.865 | -1.143 | -0.686 | -1.293 | -1.08 | -0.212 | -0.21 |
| EBITDA Ratio
| -9.166 | -11.363 | -3.059 | -1.897 | -0.964 | -1.27 | -0.971 | -0.742 | -1.583 | -1.776 | -0.188 | -0.159 |